Reem Suliman (R S Alazragi)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 11

Top Topics

Hyaluronic Acid

Top Venues

Neurology and therapy

Neurology international

Brazilian journal of biology = Revista brasleira de biologia

This page only lists publications with an associated author ORCID identifier.

Publications

Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study. Neurology and therapy 13 (2) (2024)
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study. Neurology and therapy 13 (2) (2024)
Mohamed Ezzat Abd El-Hack, Mahmoud Kamal, Reem Suliman, R M Alreemi, Alaa Qadhi, Khloud Ghafouri, Wedad Azhar, Afnan M Shakoori, N Alsaffar, H M Naffadi, Ayman E Taha, Sameh A Abdelnour
Impacts of chitosan and its nanoformulations on the metabolic syndromes: a review. Brazilian journal of biology = Revista brasleira de biologia 83 (2024)
Mohamed Ezzat Abd El-Hack, Mahmoud Kamal, Reem Suliman, R M Alreemi, Alaa Qadhi, Khloud Ghafouri, Wedad Azhar, Afnan M Shakoori, N Alsaffar, H M Naffadi, Ayman E Taha, Sameh A Abdelnour
Impacts of chitosan and its nanoformulations on the metabolic syndromes: a review. Brazilian journal of biology = Revista brasleira de biologia 83 (2024)
Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Batool Aldaher, Ahmed Al Fardan, Hajir Al Barrawy, Yazan Bader, Jonna Lyn Supena, Kathrina Alejandro, Taoufik Alsaadi
Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study. Neurology international 16 (1) (2024)
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study. Neurology and therapy 13 (2) (2024)
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study. Neurology and therapy 13 (2) (2024)
Taoufik Alsaadi, Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Princess Carmina, Batool Aldaher, Shadi Haddad, Yazan Bader
Safety and Tolerability of Combining CGRP Monoclonal Antibodies with Gepants in Patients with Migraine: A Retrospective Study. Neurology and therapy (2024)
Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Batool Aldaher, Ahmed Al Fardan, Hajir Al Barrawy, Yazan Bader, Jonna Lyn Supena, Kathrina Alejandro, Taoufik Alsaadi
Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study. Neurology international 16 (1) (2024)
Reem Suliman, Vanessa Santos, Ibrahim Al Qaisi, Batool Aldaher, Ahmed Al Fardan, Hajir Al Barrawy, Yazan Bader, Jonna Lyn Supena, Kathrina Alejandro, Taoufik Alsaadi
Effectiveness of Switching CGRP Monoclonal Antibodies in Non-Responder Patients in the UAE: A Retrospective Study. Neurology international 16 (1) (2024)
Yazan Bader, Reem Suliman, Mohamad Harb, Vanessa Santos, Ibrahim Al Qaisi, Taoufik Alsaadi
Effectiveness and Safety of Eptinezumab in Episodic and Chronic Migraine Headache in the UAE: A Retrospective Study. Neurology and therapy (2023)